Status:
TERMINATED
Analysis of Antihypertensive Treatment Efficacy
Lead Sponsor:
AstraZeneca
Conditions:
Arterial Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Analysis of antihypertensive treatment efficacy.
Eligibility Criteria
Inclusion
- arterial hypertension
- intake of Atacand before study enrollment
Exclusion
- hypersensitivity to candesartan or any other ingredient of Atacand
- liver function impairment and/or cholestasis
- severe renal insufficiency (serum creatinine \> 265 µmol/L)
- Pregnant and lactating women
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2009
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00767247
Start Date
May 1 2008
End Date
February 1 2009
Last Update
December 3 2010
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Arhangelsk, Russia
2
Research Site
Bryansk, Russia
3
Research Site
Domodedovo, Russia
4
Research Site
Dzerzhinsk, Russia